CN103420865B - A kind of generation and synthesis method of chiral amide crystal compound - Google Patents

A kind of generation and synthesis method of chiral amide crystal compound Download PDF

Info

Publication number
CN103420865B
CN103420865B CN201310377949.9A CN201310377949A CN103420865B CN 103420865 B CN103420865 B CN 103420865B CN 201310377949 A CN201310377949 A CN 201310377949A CN 103420865 B CN103420865 B CN 103420865B
Authority
CN
China
Prior art keywords
chiral
oac
crystal compound
except desolventizing
chiral amide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310377949.9A
Other languages
Chinese (zh)
Other versions
CN103420865A (en
Inventor
罗梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310377949.9A priority Critical patent/CN103420865B/en
Publication of CN103420865A publication Critical patent/CN103420865A/en
Application granted granted Critical
Publication of CN103420865B publication Critical patent/CN103420865B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A kind of chiral amide crystal compound (I), its chemical formula is as follows: the synthetic method of this chiral amide crystal compound (I) in chlorobenzene, has Cu (OAc) with 3-[1-(2-carbonyl) pyrrolidyl]-propionitrile and chiral D-benzene glycinol 2h 2when O exists under anhydrous and oxygen-free condition back flow reaction 50 hours, Cu (OAc) 2h 2o consumption is the 59.4mol%(molar percentage of material quantity); Reduce pressure with except desolventizing, by residuum water dissolution, and use CHCl 3(20mLx2) extract, organic phase anhydrous sodium sulfate drying, rotate except desolventizing, by thick product sherwood oil/methylene dichloride (1:100) column chromatography, volatilize last component point naturally, obtains clear crystal.

Description

A kind of generation and synthesis method of chiral amide crystal compound
One, technical field
The present invention relates to a kind of new compound and preparation method thereof, particularly a kind of chipal compounds and preparation method thereof, the preparation of (2R)-2-acetylaminohydroxyphenylarsonic acid 2-ethyl phenylacetate and synthetic method thereof.
Two, background technology
(2R)-2-acetylaminohydroxyphenylarsonic acid 2-ethyl phenylacetate is important medicine intermediate, and its synthetic method has lot of documents report [1-4]:
Reference:
1.Microwave-Assisted Synthesis of Amide under Solvent-free Conditions,Wang,Xiao-Jian;Yang,Qian;Liu,Fei;You,Qi-Dong,Synthetic Communications(2008),38(7),1028-1035.
2.Highly efficient deacetylation by use of the neutral organotin catalyst[tBu2SnOH(Cl)]2,Orita,Akihiro;Hamada,Yuuki;Nakano,Takehiko;Toyoshima,Shinji;Otera,Junzo Chemistry-AEuropean Journal(2001),7(15),3321-3327.
3.[tBu2SnOH(Cl)]2as a highly efficient catalyst for deacetylation,Orita,Akihiro;Sakamoto,Katsumasa;Hamada,Yuuki;Otera,Junzo,Synlett(2000),(1),140-142.
4.Study of the resolution of amino acids and amino alcohols in organic solvents,Orsini,F.;Pelizzoni,F.;Ghioni,C.,Amino Acids(1995),9(2),135-140。
Three, summary of the invention
The present invention is intended to particularly to prepare chiral drug for asymmetric synthesis field provides chipal compounds part needed for a kind of efficient chiral catalyst, and technical problem to be solved is selected corresponding raw material and sets up corresponding method synthesis of chiral catalyst ligand.
(1) chipal compounds alleged by the present invention is the compound shown in following chemical formula I:
Its chemical name: (2R)-2-acetylaminohydroxyphenylarsonic acid 2-ethyl phenylacetate, is called for short compound (I).
The synthetic method of chipal compounds (I) is that 3-[1-(2-carbonyl) pyrrolidyl]-propionitrile and chiral D-benzene glycinol synthesize in organic solvent under catalyzer copper acetate dihydrate 59.4mol% existence condition, and chemical equation is as follows:
This chipal compounds (I) synthetic method comprises synthesis, abstraction and purification, and described synthesis is that 3-[1-(2-carbonyl) pyrrolidyl]-propionitrile and chiral D-benzene glycinol have Cu (OAc) in chlorobenzene 2h 2when O exists under anhydrous and oxygen-free condition back flow reaction 50 hours, Cu (OAc) 2h 2o consumption is the 59.4mol% (molar percentage, lower same) of material quantity; Reduce pressure with except desolventizing, by residuum water dissolution, and use CHCl 3(20mLx2) extract, organic phase anhydrous sodium sulfate drying, rotate except desolventizing, by thick product sherwood oil/methylene dichloride (1:100) column chromatography, volatilize last component point naturally, obtains clear crystal,
The reaction mechanism of this reaction can be presumed as follows:
3-[1-(2-carbonyl) pyrrolidyl]-propionitrile and the effect of a large amount of Lewis acid copper acetate dihydrate, discharge two molecule acetic acid, again with chirality (S)-benzene glycinol effect, intramolecular condensation sloughs two molecular waters, forms target compound I.
The preparation of this chipal compounds, adopts simple and easy, efficient methodology of organic synthesis, one-step synthesis chipal compounds, and through X-diffraction, its structure is determined in NMR, IR and ultimate analysis.
Four, accompanying drawing explanation
Fig. 1 is the single crystal diffraction figure of compound (I).
Five, embodiment
1. the preparation of (2R)-2-acetylaminohydroxyphenylarsonic acid 2-ethyl phenylacetate
In 100mL two-mouth bottle, under anhydrous and oxygen-free condition, add Cu (OAc) 2h 2o1.7852g (8.97mmol), 40ml chlorobenzene, 3-[1-(2-carbonyl) pyrrolidyl]-propionitrile 2.833g (15.1mmol), D-benzene glycinol 2.0g, at high temperature reflux mixture 50h, stopped reaction, reduces pressure to remove desolventizing, by residuum water dissolution, and use CHCl 3(20mLx2) extract, organic phase anhydrous sodium sulfate drying, rotate except desolventizing, by thick product sherwood oil/methylene dichloride (1:100) column chromatography, volatilize last component point naturally, obtains clear crystal, productive rate: 40%; M.p.:115-117, [a] 5 d=+69.8 ° of (c=0.082, CH 3oH); 1hNMR (500MHz, CDCl 3, 27 DEG C), δ (ppm)=7.25 ~ 7.37 (m, 5H), 6.02 (s, 1H), 5.30 (dt, 1H), 4.24 ~ 4.27 (m, 2H), 2.03 ~ 2.05 (d, J=15Hz, 6H), HRMS (EI): m/z (%): calcd for C 12h 15nO 3: 221.1046; Found:221.1043, this match crystal volume data is as follows:
The typical bond distance's data of crystal
The typical bond angle data of crystal:
(2), nitrile silicification reaction application
0.20mmol chipal compounds (I), 2-tolyl aldehyde 0.1mL, TMSCN 0.3ml (3.3mmol) add, after 3d in succession at 20 ~ 30 DEG C, add shrend and go out after post layer that (sherwood oil/methylene dichloride: 5/1), obtains colourless oil liquid.Transformation efficiency: 52%, ee%:20%; 1h NMR (300MHz, CDCl 3) 7.52 – 7.53 (d, 7.5Hz, 1H), 7.20 – 7.30 (m, 3H), 5.57 (s, 1H), 2.44 (s, 3H), 0.22 (s, 9H). 13c NMR (75MHz, CDCl 3) 135.8,134.2,131.2,129.5,127.1,126.6,118.9,62.1,18.9 ,-0.2 (X3).

Claims (1)

1. one kind has the chiral amide crystal compound (I) of following structural formula synthetic method, comprise synthesis and be separated, it is characterized in that: described synthesis 3-[1-(2-carbonyl) pyrrolidyl]-propionitrile and chiral D-benzene glycinol have Cu (OAc) in chlorobenzene 2h 2when O exists under anhydrous and oxygen-free condition back flow reaction 50 hours, Cu (OAc) 2h 2o consumption is the 59.4mol% molar percentage of material quantity; Reduce pressure with except desolventizing, by residuum water dissolution, and use CHCl 320mLx2 extracts, organic phase anhydrous sodium sulfate drying, rotates except desolventizing, and by thick product sherwood oil/methylene dichloride 1:100 column chromatography by volume, volatilize last component point naturally, obtains clear crystal.
CN201310377949.9A 2013-08-27 2013-08-27 A kind of generation and synthesis method of chiral amide crystal compound Active CN103420865B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310377949.9A CN103420865B (en) 2013-08-27 2013-08-27 A kind of generation and synthesis method of chiral amide crystal compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310377949.9A CN103420865B (en) 2013-08-27 2013-08-27 A kind of generation and synthesis method of chiral amide crystal compound

Publications (2)

Publication Number Publication Date
CN103420865A CN103420865A (en) 2013-12-04
CN103420865B true CN103420865B (en) 2015-08-26

Family

ID=49646297

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310377949.9A Active CN103420865B (en) 2013-08-27 2013-08-27 A kind of generation and synthesis method of chiral amide crystal compound

Country Status (1)

Country Link
CN (1) CN103420865B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104557586B (en) * 2015-01-25 2017-01-18 罗梅 Preparation and synthesis method of chiral amide compound

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024115A1 (en) * 1993-04-16 1994-10-27 Santen Pharmaceutical Co., Ltd. Novel piperazine derivative
US20060178438A1 (en) * 2003-03-21 2006-08-10 Allen Jennifer R Muscarinic agonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001172210A (en) * 1999-12-15 2001-06-26 Sumitomo Chem Co Ltd Method for producing alcoholic compound

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024115A1 (en) * 1993-04-16 1994-10-27 Santen Pharmaceutical Co., Ltd. Novel piperazine derivative
US20060178438A1 (en) * 2003-03-21 2006-08-10 Allen Jennifer R Muscarinic agonists

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ber Aminosäure-Antagonisten, V Trennung und Bestimmung der Konfigurationen der stereoisomeren N-Acetyl-2-(2′-cyclopentenyl)glycine.《Liebigs Annalen der Chemie》.1981,第1981卷(第4期),第644页化合物8,第654页倒数第1-3行和第655页第1-4行. *
Microwave-Assisted Synthesis of Amide under Solvent-free Conditions;Wang, Xiao-Jian 等;《synthetic Communications》;20081231;第38卷(第7期);第1028-1035页 *
Santoso, Sentot 等.&Uuml *
Stereoselective aldol reaction with (R)-N-acetyl-α-phenylglycinol;Braun,Mandred 等;《Angewandte Chemie》;19831031;第22卷(第10期);第783页化合物4c *
Stereoselective aldol reactions with chiral secondary acetamides;Devant,Ralf 等;《Chemische Berichte》;19861231;第119卷(第7期);第2195页第1段及化合物15 *
The Correlation of the configurations of α-aminophenylacetic acid and of alanine;Kuna,Martin 等;《Journal of Biological Chemistry》;19411231;第137卷;第337-342页 *

Also Published As

Publication number Publication date
CN103420865A (en) 2013-12-04

Similar Documents

Publication Publication Date Title
CN104152525B (en) A kind of method that fractionation prepares the phenyl ethylamines of optical voidness R 1
CN108516992A (en) Photocatalytic synthesis at 1- aryl cyclopropyl phosphonate esters method
CN105859622A (en) Method for palladium-catalysis asymmetric hydrogenation synthesis of chiral fluorinated pyrazolone derivatives
CN103524320A (en) Substituted benzophenone and preparation method thereof
CN103420865B (en) A kind of generation and synthesis method of chiral amide crystal compound
CN103193608A (en) Method for preparing dimethoxy benzaldehyde from veratrole
CN102391154B (en) Alpha-hydroxyl-beta-aminoketone derivatives, synthetic method and application thereof
CN104774174B (en) A kind of method of asymmetric syntheses S carbinoxamines
CN105218329A (en) Clean analogue intermediate of a kind of row and preparation method thereof
CN103804178B (en) A kind of caffeinic synthetic method
CN101492351A (en) Process for producing asarin
CN102336699B (en) Chiral compound
CN103570578B (en) Synthetic method for chiral amide crystal compound
CN105272918B (en) Halogenation -1- alkyl -3- vinyl -2,4,5- triarylimidazoles and preparation method and purposes
CN104003929B (en) A kind of synthetic method of α, α-diphenyl-4-piperidine carbinols
CN107663185A (en) Synthesis method of butyrolactone derivative
CN106243073B (en) A kind of 2-H 1-benzopyran derivatives and its synthetic method
CN103254051B (en) A kind of preparation method of dialkyl curcumin
CN104529726A (en) Preparation method of hydroxyacetophenone
CN104591939B (en) A kind of method preparing xenyl acrylic acid ether compound
CN105884724B (en) A kind of preparation method of benzofuran compounds
CN109422673A (en) A method of synthesis indole ketone compound containing iodine
CN102408389B (en) Lactic acid-glutamic acid morpholine dione and synthetic process method thereof
CN101519683B (en) Method for resolving and purifying chiral aromatic alcohol compound and partial intermediate products and final products thereof
CN108264489A (en) A kind of method for synthesizing quinazoline in water

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant